GlobalData on MSN1d
Health Canada approves MSD’s Keytruda for NSCLC stages
Health Canada has approved MSD's anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...
Indaptus receives approval from Health Canada to expand trial of Decoy20
Indaptus Therapeutics (INDP) announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial ...
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
Yahoo Finance8d
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
Health Canada’s approval followed a comprehensive review of our safety data and trial design. Expanding to Canada represents a significant step in our mission to evaluate Decoy20, a broad immune ...